Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Sep 24, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, 6-k, disclosure, pharmaceuticals
TL;DR
DRL filed a 6-K, confirming 20-F reporting. Standard procedure.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on September 24, 2024, to report information as a foreign private issuer. The filing confirms their submission of annual reports under Form 20-F. The company is based in Hyderabad, Telangana, India, and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing is a routine disclosure for foreign private issuers, providing an update on their reporting status and corporate information to the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing by a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 0001575872-24-001020 (accession_number) — Filing identifier
- 20240924 (date) — Filing date
- Hyderabad, Telangana, India (location) — Company headquarters
- 2834 (sic_code) — Pharmaceutical Preparations industry
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report information as a foreign private issuer to the SEC, confirming their submission of annual reports under Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on September 24, 2024.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
Dr. Reddy's Laboratories Ltd. is headquartered in Hyderabad, Telangana, India.
What is the Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Ltd.?
The SIC code for Dr. Reddy's Laboratories Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Does this filing indicate submission in paper format?
The filing includes checkboxes for paper submission under Regulation S-T Rule 101(b)(1) and 101(b)(7), but the presence of 'x' next to Form 20-F suggests standard electronic filing procedures are being followed, not specifically paper submission for this report.
Filing Stats: 405 words · 2 min read · ~1 pages · Grade level 16.9 · Accepted 2024-09-24 06:21:23
Filing Documents
- drr0673_6k.htm (6-K) — 13KB
- drr0673_ex99-1.htm (EX-99.1) — 6KB
- drr0673_ex99-1img01.jpg (GRAPHIC) — 7KB
- drr0673_ex99-1img02.jpg (GRAPHIC) — 10KB
- 0001575872-24-001020.txt ( ) — 43KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: September 22, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3